Cardiol Therapeutics Presentation of Phase II ARCHER Trial Results

Past Event Nasdaq Amplify Spotlight – Cardiol Therapeutics: Featuring President & CEO, David ElsleyOct 26, 2025

Past Event The KE Report Podcast: Cardiol Therapeutics – Advancing Breakthrough Therapies for Inflammatory Heart DiseaseSep 02, 2025

Past Event H.C. Wainwright 27th Annual Global Investment ConferenceSep 09 - Sep 09, 2025